Define: Tentative Approval
In a contract, Tentative Approval refers to a regulatory status confirming a drug product meets safety, efficacy, and quality requirements but cannot yet be marketed because of existing patent or exclusivity protections. Contracts reference this status to define milestones, licensing rights, and timing obligations tied to eventual full approval and commercial launch, particularly in pharmaceutical licensing and supply agreements.
Legal accuracy standard set & glossary spot-checked by Imad Mohammed Nazar , Skadden-trained M&A lawyer, Legal Engineer at GenieAI
What Tentative Approval Means in a Contract
Tentative Approval is a regulatory designation used primarily in pharmaceutical development contracts to describe a product that has satisfied all scientific and quality requirements for marketing but is legally barred from sale due to another party's patent rights or market exclusivity period. In contractual language, this term functions as a defined status that triggers or delays specific obligations, such as royalty payments, manufacturing scale-up, or distribution rights.
Parties to licensing agreements, supply agreements, or research collaboration contracts often build entire timelines around the moment a product achieves Tentative Approval versus full approval. The distinction matters because Tentative Approval confirms technical and regulatory readiness while explicitly acknowledging that commercial launch remains legally restricted until the blocking patent expires or is otherwise resolved.
This creates a unique contractual middle ground where a product is simultaneously validated and restrained, requiring careful drafting to address what rights and obligations attach during this waiting period.
How Tentative Approval Is Defined or Measured
Tentative Approval is typically measured against the standards set by the relevant regulatory authority governing pharmaceutical products in the jurisdiction where the contract operates. The measurement criteria usually include verified safety data, demonstrated efficacy through clinical trials, and confirmation that manufacturing quality standards have been met.
What separates Tentative Approval from full approval is not a difference in scientific merit but rather a legal obstacle, most commonly patent protection or statutory market exclusivity held by a competing party. Contracts often incorporate this definition by reference to the applicable regulatory framework, avoiding restating technical criteria and instead cross-referencing the relevant approval letter or regulatory filing.
- Confirmation that safety and efficacy data have been reviewed and accepted
- Verification that manufacturing quality controls meet required standards
- Identification of the specific patent or exclusivity barrier preventing marketing
- An anticipated date or event triggering conversion to full approval
Where Tentative Approval Appears in Agreements
This term appears most frequently in pharmaceutical licensing agreements, patent settlement agreements, and supply or distribution contracts where the parties need to coordinate around a delayed market entry. It also surfaces in Relevant Circumstances
Relevant Sectors